loader image
Wednesday, December 10, 2025
59.6 F
McAllen
- Advertisement -

New Targets in Developing Dementia Treatments

Beyond Amyloid and Tau

Translate to Spanish or other 102 languages!

Recently, this amyloid hypothesis has been questioned, and there has been a huge upsurge in dementia research.  Image for illustration purposes
Recently, this amyloid hypothesis has been questioned, and there has been a huge upsurge in dementia research. Image for illustration purposes

Medical News Today

- Advertisement -

Alzheimer’s disease is the most common form of dementia. Although its exact cause is unknown, for many years scientists have believed that a protein called beta-amyloid was responsible. Recently, this amyloid hypothesis has been questioned, and there has been a huge upsurge in dementia research. Here, we round up the latest findings, look at possible advances in diagnosis, and ask: Where next for Alzheimer’s research and treatment?

To read the full story, follow the link below to Medical News Today:

https://www.medicalnewstoday.com/articles/beyond-amyloid-and-tau-new-targets-in-developing-dementia-treatments

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Most People Trust Doctors Over AI but See Promise for Cancer Diagnosis

Mega Doctor News By Society for Risk Analysis (SRA) Newswise — Washington, D.C. – New...

Simple Ways to Reduce Inflammation and Protect Your Heart

Mega Doctor News By American Heart Association If you’ve ever fought off an...

ACS Cervical Cancer Screening Guidelines Updates

According to the World Health Organization (WHO), in 2022 cervical cancer was the fourth most common cancer among womenTrusted Source worldwide, with about 660,000 new cases.

MD Anderson Unveils Breakthroughs in Blood Cancer Treatment

Researchers from The University of Texas MD Anderson Cancer Center presented groundbreaking research at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition.
- Advertisement -
×